From: Predictors of very early stroke recurrence in the POINT trial population
Predictor | Model A | Model B | ||
---|---|---|---|---|
Beta (+/− S.E.) | O.R. [95% limits] | Beta (+/− S.E.) | O.R. [95% limits] | |
Intercept | −5.89 +/− 0.49** | – | −6.86 +/− 0.71** | – |
Hypertension hx | 0.20 +/− 0.18 | 1.22 [0.85, 1.74] | 0.118 +/− 0.190 | 1.13 [0.78, 1.63] |
Glucose (per 10 mg/dL) | 0.023 +/− 0.010* | 1.02 [1.00, 1.04] | 0.027+/− 0.010** | 1.03 [1.01, 1.05] |
Systolic BP (per 10 mmHg) | 0.117 +/− 0.033** | 1.12 [1.05, 1.20] | 0.098 +/− 0.034** | 1.10 [1.03, 1.18] |
Diastolic BP (per 10 mmHg) | 0.004 +/− 0.052 | 1.00 [0.91, 1.11] | 0.028 +/− 0.056 | 1.03 [0.92, 1.15] |
Cohort | 0.62 +/− 0.17** | 1.86 [1.34, 2.58] | 0.61 +/− 0.19** | 1.86 [1.33, 2.58] |
PUD history | – | – | − 0.55 +/− 1.02 | 0.58 [0.08, 4.27] |
Age | – | – | 0.016 +/− 0.007* | 1.02 [1.00, 1.03] |
Racea | – | – | 0.45 +/− 0.18* | 1.57 [1.10, 2.25] |
Statin use | – | – | −0.38 +/− 0.17* | 0.68 [0.49, 0.95] |
Carotid imaging resultsb | – | – | 1.02 +/− 0.26** | 2.77 [1.78, 4.31] |
Treatment | −0.49 +/− 0.16** | 0.62 [0.45, 0.84] | −0.47 +/− 0.16** | 0.62 [0.46, 0.85] |